These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1801636)

  • 1. Therapy of established experimental Pseudomonas aeruginosa infections with oral ciprofloxacin and five human monoclonal antibodies against lipopolysaccharide antigens.
    Collins MS; Ladehoff D; Mehton NS
    Antibiot Chemother (1971); 1991; 44():185-95. PubMed ID: 1801636
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of experimental Pseudomonas burn wound sepsis with ciprofloxacin and Pseudomonas immune globulin.
    Collins MS; Tsay GC; Hector RF; Roby RE; Dorsey JH
    Antibiot Chemother (1971); 1987; 39():222-32. PubMed ID: 3118784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of gram-negative and gram-positive infections with 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection with intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS; Hector RF; Roby RE; Edwards AA; Ladehoff DK; Dorsey JH
    Infection; 1987; 15 Suppl 2():S51-9. PubMed ID: 3112021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa.
    Collins MS; Ladehoff DK; Mehton NS; Noonan JS
    FEMS Microbiol Immunol; 1990 Dec; 2(5-6):263-8. PubMed ID: 2127368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo functional activities of monoclonal antibodies reactive with Pseudomonas aeruginosa serogroup 6 lipopolysaccharides.
    Pollack M; Tao M; Akiyama M; Pier GB; Koles NL
    Antibiot Chemother (1971); 1991; 44():163-71. PubMed ID: 1801635
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN; Holder IA
    Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788
    [No Abstract]   [Full Text] [Related]  

  • 7. Feasibility of prophylaxis and therapy against gram-negative infections by human monoclonal antibodies.
    Lang AB; Fürer E; Cryz SJ
    FEMS Immunol Med Microbiol; 1993 Jun; 7(1):9-13. PubMed ID: 8364527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic human monoclonal antibodies directed to Pseudomonas aeruginosa].
    Noguchi H
    Nihon Rinsho; 1991 Oct; 49(10):2446-51. PubMed ID: 1749102
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
    Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
    Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa.
    Schreiber JR; Patawaran M; Tosi M; Lennon J; Pier GB
    J Immunol; 1990 Feb; 144(3):1023-9. PubMed ID: 2104908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bacterial motility with human antiflagellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat.
    Landsperger WJ; Kelly-Wintenberg KD; Montie TC; Knight LS; Hansen MB; Huntenburg CC; Schneidkraut MJ
    Infect Immun; 1994 Nov; 62(11):4825-30. PubMed ID: 7927761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE; Pier GB; Sadoff JC; Small GJ
    Rev Infect Dis; 1986; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of "nubiotics" against burn wound infection by Pseudomonas aeruginosa.
    Dale RM; Schnell G; Wong JP
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2918-23. PubMed ID: 15273101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
    Holder IA; Naglich JG
    J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic and protective properties of a murine lipopolysaccharide-specific monoclonal antibody in experimental Pseudomonas aeruginosa pneumonia in mice.
    Oishi K; Sonoda F; Miwa H; Tanaka H; Watanabe K; Matsumoto K; Pollack M
    Microbiol Immunol; 1991; 35(12):1131-41. PubMed ID: 1808464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
    Minukhin VV; Tsyganenko AIa
    Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
    Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
    Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa.
    Sawada S; Kawamura T; Masuho Y; Tomibe K
    J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
    Naqvi SH; Naqvi SH
    S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.